Cargando…
A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
OBJECTIVE: Glucose-based positron emission tomography (PET) imaging has been widely used to predict the progression of mild cognitive impairment (MCI) into Alzheimer's disease (AD) clinically. However, existing discriminant methods are unsubtle to reveal pathophysiological changes. Therefore, w...
Autores principales: | Wang, Min, Yan, Zhuangzhi, Xiao, Shu-yun, Zuo, Chuantao, Jiang, Jiehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450311/ https://www.ncbi.nlm.nih.gov/pubmed/32908613 http://dx.doi.org/10.1155/2020/2825037 |
Ejemplares similares
-
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020) -
Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep
Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019) -
Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019) -
Radiomics: a novel feature extraction method for brain neuron degeneration disease using (18)F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment
por: Li, Yupeng, et al.
Publicado: (2019) -
Combining PET with MRI to improve predictions of progression from mild cognitive impairment to Alzheimer’s disease: an exploratory radiomic analysis study
por: Yang, Fan, et al.
Publicado: (2022)